A recent meta-analysis study reviewed twelve randomized controlled trials (RCTs) (n = 791) and found that ALC supplementation significantly reduced depressive symptoms in MDD as monotherapy and augmentation compared to placebo, with effect sizes comparable to standard antidepressants and a superior safety profile
safety depends on patient selection, dose titration, and ongoing medical oversightall components PlexusDx provides through its physician-supervised model
If you've been on a stable compounded dose for weeks or months, your prescriber can individualize the starting dose based on your treatment history
Ro is also well-suited for people who value personalized, provider-led care
Complaints focus on shipping delays (especially in California) and intermittent support-response times during peak periods
ARCHITECT System Operations Manual 201837-113 - 2016-04-29 (Abbott Park, IL 60064 USA2016)